Companies

Products

Services

Software

Training

Applications

Sign in

List your business

Advertising options

About

news
gesynta pharma initiates phase ii study of its first in class drug candidate gs 248 in patients with

SHARE

Jul. 5, 2025

Courtesy of

Contact supplier

Drop file here or browse

Yes, please send to similar suppliers.

Stay in the loop!

Select your areas of interest to receive industry updates.

JOIN OUR MAILING LIST

Back to top

About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

Medical Industry Products
Medical Industry Software
Medical Industry Training
Medical Industry Services
Medical Industry Applications

Latest

Medical Industry News

Medical Industry Events

Publications

Medical Industry Articles

Medical Industry Books

Medical Industry Magazines

Medical Industry Downloads

Medical Industry Videos

Companies

Medical Industry Companies

FAQs
Company sitemap
Category sitemap

Medical XPRT is part of XPRT Media All Rights Reserved.

Terms

Privacy

Our sites:

Environmental XPRT

Agriculture XPRT

Energy XPRT

XPRT